Dr. Kieron Leslie
Dr. Kieron Leslie is a professor of dermatology at the University of California, San Francisco (UCSF). He graduated from St. Bartholomew's and The Royal London School of Medicine, and completed his general medical training at the Royal Free and University College hospitals in London. He completed his dermatology training in London and Norwich, UK. He is also a graduate of the London School of Hygiene and Tropical Medicine where he attained Diploma of Tropical Medicine & Hygiene (DTM&H). His research and clinical interests fall in to 2 separate areas. The first being autoinflammatory diseases where Dr. Leslie helped to define the clinical phenotype of Cryopyrin Associated Periodic Syndrome (CAPS). He was part of the team that led to licensing of canakinumab (Ilaris) as a treatment for CAPS in both Europe and the USA. He has also studied the role of autoinflammatory in other skin conditions, such as hidradenitis suppurativa. His other interest is skin diseases as complications of HIV. He now directs the HIV Dermatology Clinic at San Francisco General Hospital. An expanding area of clinical care and research is Kaposi's Sarcoma. He is extensively published in dermatology journals such as JAAD, JAMA Derm & BJD and also general medical journals such as the New England Journal of Medicine and the Journal of Experimental Medicine.